FBXW7 and neoplasm: We have previously reported novel mutations in the WD40 domain of FBXW7 preventing degradation of NOTCH1 in ATL cells and decreased in vivo tumor growth by blockade of NOTCH1-dependent growth of ATL cells [10, 11].